The market’s most investable theme today is not simply artificial intelligence, healthcare or macroeconomics in isolation. It is possibly the increasingly visible convergence of all three: businesses finding ways to monetize AI, healthcare platforms turning operational discipline into financial leverage, and policymakers…
Doximity, Inc. (NYSE: DOCS) may be sitting at the intersection of two stubborn healthcare realities: physicians are exhausted by administrative overload, and the system cannot easily afford to lose more of them. Its emerging AI opportunity is compelling precisely because it is not…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
U.S. equities finished lower on Tuesday, August 11, 2026, extending a modest two-session pullback from recent record levels. Concerns that a resolution to the U.S.-Iran standoff may take longer than hoped helped keep oil prices elevated, while investors positioned cautiously ahead of…
U.S. equities finished modestly lower on Monday as a sharp move higher in crude oil renewed inflation concerns ahead of this week’s key U.S. inflation data. The session reflected measured risk reduction rather than broad capitulation: volatility rose, technology lagged, and energy…
Week ending Friday, August 7, 2026 — U.S. equities finished the week decisively higher, led by technology and smaller-capitalization shares. The market’s message was nuanced: economic activity indicators remained firm, but July’s unexpected payroll decline reinforced the view that the labor market…
All major U.S. stock indexes finished lower Thursday as investors weighed fresh geopolitical risks in the Middle East, firmer Treasury yields and a murky Federal Reserve outlook against strong but increasingly priced-in enthusiasm around artificial intelligence and corporate earnings. The S&P 500…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
Amwell’s setup going into Q2 2026 looks like the kind of telehealth story Wall Street loves to rediscover right after it has ignored it for too long. The company’s August 4 aftermarket earnings report and 5 p.m. ET webcast arrive with a…
Amwell’s (AMWL) leadership page reads like a small thesis on where digital care is trying to go: a mix of clinicians, operators, and technologists built to make virtual healthcare feel less like a workaround and more like a workflow. That matters because…
